Healthcare entity
Every one of those 2 sits in a single category, regulation. Of the tracked stories, 1 of 2 also mention BakerHostetler, the most common co-covered peer. Each story carries 16.5 original sources on average, compared with 5.7 for the broader beat in this window.
Last mentioned: Aug 17, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, regulation. Of the tracked stories, 1 of 2 also mention BakerHostetler, the most common co-covered peer. Each story carries 16.5 original sources on average, compared with 5.7 for the broader beat in this window. That works out to roughly 0.5 stories per week across a 30-day span. Their average consequence score of 7 runs above the beat's 6.5 for that window. We currently track 2 Healthcare stories that mention Todd Blanche, published between June 28, 2026 and July 27, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 203 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Todd Blanche. Shared-story counts are live from our verified record — not editorial picks.
Scheduled DEA hearing on rescheduling
A DEA administrative hearing is set to take place, which CEO Duane Boise calls less significant than the appellate court action.
MMJ announces advancement of legal challenge
Company issues press release declaring that the D.C. Circuit challenge has advanced and that the operative legal event is the court review, not the upcoming DEA hearing.
Statement of Issues filed
MMJIH files a Statement of Issues in the D.C. Circuit Court of Appeals seeking vacatur of the Final Order.
Acting Attorney General issues Final Order
Todd Blanche places marijuana into Schedule III of the Controlled Substances Act via a Final Order.
Initial DEA hearing process begins
A hearing process on marijuana rescheduling begins under the Controlled Substances Act, later terminated by the government according to petitioners.
MMJ International Holdings' appeal to the D.C. Circuit exposes a procedural flaw in the DEA's marijuana rescheduling that could delay patient access to new cannabinoid medicines and create confusion for healthcare providers trying to navigate the shifting regulatory landscape.
Source: tennesseedaily.com · pr-inside.com
The massive enforcement action targets telemedicine and genetic testing schemes, highlighting new compliance risks for healthcare providers. CMS prevented $4B in claims and revoked 205 providers’ billing privileges, signaling a data-driven oversight era.
Todd Blanche is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
